Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV04
- Pharmacological subgroupV04COther diagnostic agents
- Chemical subgroupV04CDTests for pituitary function
- Chemical substanceV04CD01Metyrapone
Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 2 registrations
Spain
AEMPS · 1 registration
Croatia
HALMED · 1 registration
Netherlands
CBG-MEB · 1 registration
At a glance
- ATC code
- V04CD01
- ATC group
- Various
- Registers
- 5
- Historical lists
- 1
- Registrations
- 8
- With their own page
- 6
- Companies
- 6
All medicines with Metyrapone
Human medicines from every register that match Metyrapone by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
8 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Metopirone | United States | 250MG | capsule | Marketed | Esteve |
| Metopirone | United States | 250MG | tablet | Not marketed | Esteve |
| Metopirone 250 MG Capsulas Blandas | Spain | 250 mg | cápsula blanda | Marketed | Esteve Pharmaceuticals S.A. |
| Metopirone 250 mg capsules, zacht | Netherlands | Capsule, zacht | Authorised | Esteve Pharmaceuticals S.A. | |
| Metopirone 250 mg meke kapsule | Croatia | kapsula, meka | Marketed | Esteve Pharmaceuticals S.A. | |
| Metopirone | New Zealand | Cap 250 mg | Funded | ||
| METOPIRONE 250 mg | Romania | 250 mg | caps. moi | Status unknown | Laboratoire Hra Parma |
| METOPIRONE 250mg | Romania | 250mg | caps. moi | Status unknown | Hra Pharma Rare Diseases |